Chai J, Cameron D, Howie F, Anderson A.  A Highly-Sensitive AMH Assay Improves Analysis of Ovarian Function Following Chemotherapy for Early Breast Cancer. European Journal of Cancer 2014 Sep; 50(14):2367-74.

All Products Cited: picoAMH ELISA AL-124

 

Chai J, Howie F, Cameron DA, Anderson, RA.  Analysis of ovarian function following chemotherapy for early breast cancer using an ultra-sensitive assay.  Poster session presented at: European Society for Human Reproduction and Embryology; 2014, Jun 29 – July 2 Munich, Germany.

All Products Cited: picoAMH ELISA AL-124

 

Iwase A, Nakamura T, Nakahara T, Goto M, Kikkawa F. Anti-Mullerian Hormone and Assessment of Ovarian Reserve After Ovarian Toxic Treatment, a Systematic Narrative Review.  Reproductive Sciences. 2015 May, 22(5):519-26.

All Products Cited: AMH ELISA AL-105; picoAMH ELISA AL-124

 

Jung S, Allen N, Arslan AA, Baglietto L, Barricarte A, Brinton LA, Egleston BL, Falk RT, Fortner RT, Helzlsouer KJ, Gao Y, Idahl A, Kaaks R, Krogh V, Merritt MA, Lundin E, Onland-Moret NC, Rinaldi S, Schock H, Shu XO, Sluss PM, Staats PN, Sacerdote C, Travis RC, Tjønneland A, Trichopoulou A, Tworoger SS, Visvanathan K, Weiderpass E, Zeleniuch-Jacquotte A, Dorgan JF. Anti-Müllerian Hormone and risk of ovarian cancer in nine cohorts. Int J Cancer. 2017 Sep 18.

All Products Cited: picoAMH ELISA AL-124

 

Morse, H. Anti-Müllerian hormone as a marker of ovarian reserve in girls before, during and after treatment for childhood cancer. [Dissertation, 2017]. Lund (Sweden): Lund University.

All Products Cited: AMH ELISA AL-105; picoAMH ELISA AL-124

 

Nichols H, Baird D, Stanczyk F.  Anti-Müllerian Hormone Concentrations in Premenopausal Women and Breast Cancer Risk.  Cancer Prevention Research. 2015 April 14 epub ahead of print.

All Products Cited: AMH ELISA AL-105; picoAMH ELISA AL-124

 

Johnson L, Sammel MD, Domchek S, Schanne A, Prewitt M, Gracia C. Antimüllerian hormone levels are lower in BRCA2 mutation carriers. Fertil Steril. 2017 May;107(5):1256-1265.e6.

All Products Cited: picoAMH ELISA AL-124

 

Medica ACO, Whitcomb BW, Shliakhsitsava K, Dietz AC, Pinson K, Lam C, Romero SAD, Sluss P, Sammel MD, Su HI. Beyond Premature Ovarian Insufficiency: Staging Reproductive Aging in Adolescent and Young Adult Cancer Survivors. J Clin Endocrinol Metab. 2021 Jan 23;106(2):e1002-e1013. doi: 10.1210/clinem/dgaa797.

All Products Cited: AMH DBS ELISA AL-129; FSH DBS ELISA AL-187

 

Kumar A, Kalra B, Schanne A, Lechtenberg L, Gracia C.  Bloodspot AMH may be used to assess the impact of cancer therapies on ovarian reserve.  Poster session at American Society for Reproductive Medicine; 2015 Oct 17-21; Baltimore, Maryland

All Products Cited: AMH DBS ELISA AL-129

 

Clendenen TV, Ge W, Koenig KL, Afanasyeva Y, Agnoli C, Brinton LA, Darvishian F, Dorgan JF, Eliassen AH, Falk RT, Hallmans G, Hankinson SE, Hoffman-Bolton J, Key TJ, Krogh V, Nichols HB, Sandler DP, Schoemaker MJ, Sluss PM, Sund M, Swerdlow AJ, Visvanathan K, Zeleniuch-Jacquotte A, Liu M. Breast cancer risk prediction in women aged 35-50 years: impact of including sex hormone concentrations in the Gail model. Breast Cancer Res. 2019 Mar 19;21(1):42.

All Products Cited: picoAMH ELISA AL-124

 

Bala J, Seth S, Dhankhar R, Ghalaut VS. Chemotherapy: Impact on Anti-Müllerian Hormone Levels in Breast Carcinoma. J Clin Diagn Res. 2016 Feb;10(2):BC19-21.

All Products Cited: AMH ELISA AL-105

 

Ge W, Clendenen TV, Afanasyeva Y, Koenig KL, Agnoli C, Brinton LA, Dorgan JF, Eliassen AH, Falk RT, Hallmans G, Hankinson SE,, Hoffman-Bolton J, Key TJ, Krogh V, Nichols HB, Sandler DP, Schoemaker MJ, Sluss PM, Sund M, Swerdlow AJ,, Visvanathan K,, Liu M,, Zeleniuch-Jacquotte A. Circulating anti-Müllerian hormone and breast cancer risk: A study in ten prospective cohorts. Int J Cancer. 2018 Jun 1;142(11):2215-2226.

All Products Cited: AMH ELISA AL-105; picoAMH ELISA AL-124

 

Lambert-Messerlian G, Steinhoff M, Kumar A, Eklund EE, Moore R. Comparison of Inhibin Alpha Subunit and Antimüllerian Hormone Immunoreactivity in Granulosa Cell and Mucinous Ovarian Tumors. Appl Immunohistochem Mol Morphol. 2017 Jan;25(1):71-77.

All Products Cited: Inhibin alpha antibodies; AMH antibodies; Total Inhibin ELISA AL-134; AMH ELISA AL-105

 

Kim SY, Ebbert K, Cordeiro MH, Romero MM, Whelan KA, Suarez AA, Woodruff TK, Kurita T Constitutive Activation of PI3K in Oocyte Induces Ovarian Granulosa Cell Tumors. Cancer Res. 2016 Jul 1;76(13):3851-61

All Products Cited: Activin A ELISA AL-110; Inhibin A ELISA AL-123; Inhibin B ELISA AL-107

 

Haltia UM, Hallamaa M, Tapper J, Hynninen J, AlLhan H, Ritvos O, Heikinheimo M, Unkila-Kallio L, Perheentupa A, Farkkila A.  Diagnostic markers for patients with ovarian granulosa cell tumors; comparative analysis of CA125, HE4, Inhibin B, and AMH.  Presented at 8th Ovarian Cancer Research; 2016 May 15-17; Niagra Falls, ON, Canada.

All Products Cited: AMH ELISA AL-105

 

Decanter C, Cloquet M, Dassonneville A, D’Orazio E, Mailliez A, Pigny P. Different patterns of ovarian recovery after cancer treatment suggest various individual ovarian susceptibilities to chemotherapy. Reprod Biomed Online. 2018 Jun;36(6):711-718.

All Products Cited: AMH (pico) ELISA AL-124

 

Mamsen LS, Bøtkjær JA, Kristensen SG, Pors SE, Jeppesen JV, Kumar A, Kalra B, Ernst E, Andersen CY. High Variability of Molecular Isoforms of AMH in Follicular Fluid and Granulosa Cells From Human Small Antral Follicles. Front Endocrinol (Lausanne). 2021 Mar 2;12:617523. doi: 10.3389/fendo.2021.617523.

All Products Cited: AMH Antibodies; AMH ELISA AL-105

 

Shandley LM, Fothergill A, Spencer JB, Mertens AC, Cottrell HN, Howards PP. Impact of cancer treatment on risk of infertility and diminished ovarian reserve in women with polycystic ovary syndrome. Fertil Steril. 2018 Mar;109(3):516-525.e1.

All Products Cited: AMH ELISA AL-105; picoAMH ELISA-124

 

Su HI, Kwan B, Whitcomb BW, Shliakhsitsava K, Dietz AC, Stark SS, Martinez E, Sluss PM, Sammel MD, Natarajan L. Modeling Variation in the Reproductive Lifespan of Female Adolescent and Young Adult Cancer Survivors Using AMH. J Clin Endocrinol Metab. 2020 Aug 1;105(8):2740–51. doi: 10.1210/clinem/dgaa172. PMID: 32270202; PMCID: PMC7329316.

All Products Cited: AMH (DBS) ELISA AL-129

 

Guedikian AA, Lee AY, Grogan TR, Abbott DH, Largaespada K, Chazenbalk GD, Dumesic DA. Reproductive and metabolic determinants of granulosa cell dysfunction in normal-weight women with polycystic ovary syndrome. Fertil Steril. 2018 Mar;109(3):508-515.

All Products Cited: AMH ELISA AL-105

 

Haltia UM, Hallamaa M, Tapper J, Hynninen J, Alfthan H, Kalra B, Ritvos O, Heikinheimo M, Unkila-Kallio L, Perheentupa A, Farkkila A. Roles of human epididymis protein 4, carbohydrate antigen 125, inhibin B and anti-Müllerian hormone in the differential diagnosis and follow-up of ovarian granulosa cell tumors. Gynecol Oncol. 2017 Jan;144(1):83-89.

All Products Cited: AMH ELISA AL-105

 

Roberts SC, Seav SM, McDade TW, Dominick SA, Gorman JR, Whitcomb BW, Su HI. Self-collected dried blood spots as a tool for measuring ovarian reserve in young female cancer survivors. Human Reproduction, Vol.31, No.7 pp. 1570–1578, 2016

All Products Cited: AMH DBS ELISA AL-129

 

Helena Morse, Maria Elfving, Aleksandra Turkiewicz, Claus Yding Andersen, Ingrid Ora Severe gonadotoxic insult manifests early in young girls treated for Ewing sarcoma. Medicine (2016) 95:33(e4512)

All Products Cited: AMH ELISA AL-105

 

Anderson RA, Su HI. The Clinical Value and Interpretation of Anti-Müllerian Hormone in Women With Cancer. Front Endocrinol (Lausanne). 2020 Oct 7;11:574263. doi: 10.3389/fendo.2020.574263.

All Products Cited: AMH (pico) ELISA AL-124

 

Decanter C, Peigne M, Mailliez A, Morschhauser F, Dassonneville A, Dewailly D, Pigny P.  Toward a better follow-up of ovarian recovery in young women after chemotherapy with a hypersensitive antimüllerian hormone assay.  Fertility and Sterility. 2014 Aug; 102(2):483-7.

All Products Cited: picoAMH ELISA AL-124